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O-succinylationStaphylococcus aureus and Staphylococcus epidermidis cause dangerous and difﬁcult to treat medical
device-related infections through their ability to form bioﬁlms. Extracellular poly-N-acetylglucosa-
mine (PNAG) facilitates bioﬁlm formation and is a vaccination target, yet details of its biosynthesis
by the icaADBC gene products is limited. IcaC is the proposed transporter for PNAG export, however a
comparison of the Ica proteins to homologous exo-polysaccharide synthases suggests that the com-
mon IcaAD protein components both synthesise and transport the PNAG. The limited distribution of
icaC to the Staphylococcaceae and its membership of a family of membrane-bound acyltransferases,
leads us to suggest that IcaC is responsible for the known O-succinylation of PNAG that occurs in
staphylococci, identifying a potentially new therapeutic target speciﬁc for these bacteria.
 2014 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Staphylococcus aureus and Staphylococcus epidermidis infections
associated with the insertion of medical devices can arise due to
their ability to form bioﬁlms on surfaces [1]. A bioﬁlm is a multi-
cellular, three-dimensional bacterial community anchored to a
surface; bacteria within a bioﬁlm are surrounded by an exopoly-
meric matrix, reducing bacterial exposure to antibiotics and the
host immune system [2]. As a result, infections involving bioﬁlms
are very difﬁcult to eradicate often leading to prolonged antibiotic
therapy and/or surgical removal of the device and the surrounding
infected tissue, placing a signiﬁcant ﬁnancial burden on health ser-
vices [3]. The ability to form a bioﬁlm is recognised as a major vir-
ulence factor of S. epidermidis in particular [4], and dissecting the
molecular mechanisms underlying staphylococcal bioﬁlm forma-
tion will aid the development of novel therapeutics. The ﬁrst-dis-
covered and most studied mechanism of intercellular adhesion in
staphylococcal bioﬁlms is mediated by the polysaccharide intercel-
lular adhesin (PIA), which is a b-1,6-linked poly-N-acetylglucosa-
mine (PNAG) molecule that is partially N-deacetylated [5–7].
More recently, both PNAG and N-deacetylated (dPNAG) have beenstudied as potential vaccine targets in therapeutic approaches
against a range of human microbial pathogens [8,9].
In both S. aureus and S. epidermidis, biosynthesis of PNAG, and
bioﬁlm formation, requires the IcaADBC proteins, encoded in the
icaADBC operon (Fig. 1); the sequences of the four proteins being
highly conserved (P79% similarity) between the two staphylococci
[10,11]. We have compared the ica encoded PNAG biosynthesis
system to analogous systems in Gram-negative bacteria and also
to Ica systems in other Gram-positive bacteria. Our analysis of pub-
lished data suggests that PNAG is likely to be synthesised and
translocated across the inner membrane by IcaA/D and that the
integral membrane protein IcaC, rather than acting as the PNAG
transporter (as proposed since its discovery in 1996) [11], is likely
to be an enzyme that adds O-linked succinyl groups to PNAG resi-
dues. Thus we present a revised model for the function of the Ica
proteins in PNAG synthesis in the Staphylococci and in Gram posi-
tive bacteria more generally.
2. Current models of PNAG synthesis in the Staphylococci
A role for the ica gene products in the synthesis of S. epidermidis
PNAG was discovered in 1996 by Götz and colleagues [11]. Inacti-
vation of genes in a three gene operon, icaABC, led to loss of detect-
able PNAG and cell aggregation. Later a fourth small gene, icaD,
was identiﬁed between icaA and icaB [12], giving the ﬁnal gene
order of icaADBC (Fig. 1). The small gene icaD is unusual in that it
Fig. 1. Arrangement of the ica operon in S. epidermidis, S. aureus and other Gram-positive bacteria. The genes are centred on icaB and coloured based on similarity to the ica
genes in S. epidermidis. Systematic gene names are indicated for each species and evidence for the presence of PNAG and O-succinylation of PNAG is indicated. No IcaR
homologues were found outside staphylococcal species. ⁄ND = Not Determined.
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end of icaB by four nucleotides [12]. Finally, a divergently tran-
scribed transcriptional regulator icaR was identiﬁed in this region,
which encodes a TetR family protein and is involved in environ-
mental regulation of icaADBC operon expression [13]. The presence
of the ica operon correlates with increased antibiotic resistance
and bioﬁlm formation in clinical isolates of S. epidermidis, where
45% of nosocomial infection isolates were found to be ica positive
[14]. Several studies have also demonstrated that synthesis of
PNAG is critical for staphylococcal bioﬁlm formation in animal
infection models [15,16], highlighting the key role for PNAG in
persistence.
Since the discovery of the ica genes, a variety of models for Ica
function have been proposed (reviewed in [17]) (Fig. 2A). Based
on sequence homology, IcaA was identiﬁed as a probableFig. 2. Schematic comparison of the models for Ica and Pga gene functions in the biosyn
Gram-positive bacteria. (B) The Pga system from the Gram-negative bacterium E. coli. (C)
added O-succinylation of the PNAG which we propose is catalysed by IcaC. In each system
The indicated degree of deacetylation and O-succinylation are not stoichiometrically acN-acetylglucosamine transferase, with a likely function in the syn-
thesis of the b-1,6-linked N-acetylglucosamine polymer [11]. IcaA
is predicted to contain four transmembrane (TM) helices [11] with
the glycosyltransferase 2 domain (GT-2, CAZY classiﬁcation, EC
2.4.1) located between TM1 and TM2 in a cytoplasmic location.
IcaD is a much smaller integral membrane protein, comprising
two predicted TM helice, that is required for full activity of IcaA
[12] but its precise role remains unclear. IcaB has been demon-
strated experimentally to be a speciﬁc PNAG N-deacetylase, and
a proportion of the PNAG (around 15–20% in S. epidermidis) is
known to be N-deacetylated [18,19]. IcaC was originally (in
1996) described as an integral membrane protein with six TM heli-
ces and was suggested to play a role in PNAG export [11]; later
work suggested that it must be coexpressed with IcaA/IcaD and
was needed to produce ‘mature’ PNAG that could be recognisedthesis of PNAG. (A) The current model of Ica gene function in PNAG biosynthesis in
Our reﬁned model that has a different route for PNAG export through IcaA/D and the
shared components are coloured blue and unique components are coloured green.
curate and are for illustrative purposes only.
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type cells [12]. Given its importance in infection, there is consider-
able interest in bioﬁlm formation by S. epidermidis and S. aureus
and thus there have been many reviews on the subject (for
example [17]). However, in the absence of an alternative proposal,
these reviews have reinforced the idea that the IcaAD complex only
synthesises PNAG and its translocation across the bacterial cell
membrane is performed by IcaC (represented in Fig. 2A).
3. Comparison of the Ica system with the Pga system of Gram-
negative bacteria
As discussed above, the intercellular adhesin involved in
S. epidermidis bioﬁlm formation was identiﬁed as a linear array of
b-1,6-linkedN-acetylglucosamine residues [5]. A wide range of bac-
teria produce extracellular polysaccharides (EPS) and a recent
excellent reviewdrew together a diverse set of literature concerning
Gram-negative bacteria which use the ‘synthase’-type coupled syn-
thesis and secretion pathways, as opposed to Wzx/Wxy or ABC
transporter-type mechanisms [20]. One of the best studied of these
systems is encoded by the pga operon of E. coli, which produces a
similar PNAG molecule and which also mediates bioﬁlm formation
in this organism [21]. In the PgaABCD system the naming of the pro-
teins is slightly different to the Ica system, but they share a number
of key proteins (Fig. 2B). PgaC is the equivalent to IcaA, with a cyto-
plasmic GT-2 domain that is 43% identical at the amino acid level.
Likewise PgaD is a small membrane protein required for full activity
of PgaC [22], as observed for IcaD enhancing IcaA function. However,
although IcaD and PgaD are both predicted to contain two TM heli-
ces, they share no detectable sequence homology. Together PgaC
and PgaD are thought to be responsible for both the synthesis of
the PNAG chain and its export across the inner membrane [22]
(Fig. 2B). The PgaB protein is similar to IcaB in being the N-deacetyl-
ase for PNAG and the remaining protein, PgaA, is a unique outer
membrane proteinwhich is required for the PNAG to cross the extra
barrier of the Gram-negative envelope. The only component of the
Ica system that has no functional orthologue in the Pga system is
IcaC. Given that the ‘synthase’-like polysaccharide synthesis sys-
tems appear to function as stand-alone synthesis and export
machinery, this suggests that the PgaABCD system and speciﬁcally
the PgaCD proteins are necessary and sufﬁcient for PNAG assembly
and secretion through the cytoplasmicmembrane. Hence, from this
simple comparison to Gram-negative systemswhere the role of Ica-
AD is analogous to PgaCD, a role for IcaC as a direct route of PNAG
export through the cytoplasmic membrane in S. epidermidis would
require a signiﬁcant alteration in the function of a typical ‘syn-
thase’-type polysaccharide biosynthesis system.
4. The icaC gene is not present in all ica operons in Gram-
positive bacteria
To assess further the likely functions of the different ica genes in
Gram-positive bacteria we examined the published genome
sequences of Gram-positive organisms for orthologous ica gene
clusters that included both IcaA and IcaB homologues (Fig. 1).
We identiﬁed identical cluster organisations in other staphylo-
cocci, but some variations in ica clusters from a broader range of
Gram-positive bacteria (Fig. 1). We found a range of bacteria out-
side of the staphylococci that also had clear ica clusters including
Bacillus megaterium DSM 319 and Bacillus azotoformans LMG9581,
but these clearly lack a linked icaC homologue. The only additional
organisms that had an icaC gene present were Macrococcus caseo-
lyticus JCSC5402 (Fig. 1) and Tetragenococcus halophilus (Fig. S1),
suggesting a rather limited distribution of icaC genes even within
Gram positive ica gene clusters. M. caseolyticus is the closest genusto the staphylococci and it is interesting that while many other S.
aureus virulence factors are missing from this genome [23], it has
retained what appears to be a fully functional PNAG biosynthesis
system. The conservation of a full ica operon in this organism sug-
gests that the addition of an icaC gene predates the diversiﬁcation
of the staphylococci.
5. O-succinylation of PNAG and a role for IcaC
As IcaC is not a conserved component of synthase-type polysac-
charide biosynthesis systems and is not even widely found in ica
operons in other Gram-positive bacteria, it appears to have a func-
tion speciﬁc for selected Staphylococcal species. Analysis of the
IcaC sequence identiﬁes it as being a member of a large family of
acyltransferases (Pfam Acyl_transf_3 family (PF01757) and Inter-
Pro family IPR002656) (Fig. S2). Reanalysis of the sequence of IcaC
using TMHMM conﬁrms that it is a likely 10 TM helix protein char-
acteristic of this family and not a six TM helix protein as sometimes
reported previously [11,17]. Why might S. epidermidis require this
large integral membrane protein if it is not involved directly in
export of the PNAG through the cytoplasmic membrane?
Proteins within the Acyl_transf_3 family (PF01757) have a vari-
ety of biological functions but one of the best studied members is
the S. aureus OatA protein. OatA catalyses the O-acetylation of N-
acetylmuramic acid in peptidoglycan [24]. OatA and its relatives
are thought to function by using acetyl-CoA as a donor molecule,
which is then bound and cleaved to CoA and acetate on the cyto-
plasmic side of the membrane, with the acetate being moved
across the membrane through the protein and attached to the syn-
thesised polysaccharide on the outer surface of the cytoplasmic
membrane. The closest Gram-negative match to IcaC identiﬁed
using PSI-BLAST is YiaH (WecH) of E. coli. This protein similarly
functions to transfer acetyl groups across the cytoplasmic mem-
brane for the O-acetylation of the enterobacterial common antigen
(ECA), a polymer of amino sugars [25].
There is signiﬁcant evidence in the literature that PNAG is
O-succinylated in both S. epidermidis [26] and S. aureus [27], but
how this modiﬁcation is catalysed has not been identiﬁed. It is
important to note that PNAG (PIA) had been thought to be N-succ-
inylated [28], but this has been subsequently demonstrated to be an
experimental artefact [27], while evidence for O-succinylation is
clear for both bacteria [26,27]. In S. epidermidisMack and colleagues
identiﬁed two forms of the PNAG structure, an abundant form that
is around 80% of total polysaccharide, which is ‘a linear glucosami-
noglycan’ [5], with around 15–20% of the GlcNAc residues being
deacetylated in a random pattern (the function of the IcaB protein).
However, the second form they found (polysaccharide II) was anio-
nic and contained succinyl groups present on about 6% of the Glc-
Nac residues. In S. aureus the PNAG structure is similar and O-
succinylation is thought to occur more frequently, in around 10%
of the GlcNAc groups [27]. The modiﬁcation is likely to be at the
O3 position, and a smaller amount was seen in the O4 position,
whichmight be due to spontaneousmigration of the succinyl group
around the ring after addition atO3 [27]. Given the clear presence of
this modiﬁcation and its association with S. epidermidis and S. aur-
eus, both of which contain an icaC gene in their ica clusters, we pro-
pose that IcaC is the missing O-succinyltransferase that adds
succinyl groups to the PNAG polysaccharide as it emerges from
the outer leaﬂet of the cytoplasmic membrane (Fig. 2C).
6. Concluding remarks
Given the critical health issues surrounding staphylococci and
their ability to form bioﬁlms, and the progress toward PNAG-based
vaccines, it is important to fully characterise the PNAG synthase
1872 K.E. Atkin et al. / FEBS Letters 588 (2014) 1869–1872system and ica proteins. Using genome sequence analysis and com-
parison to orthologous systems, we suggest a new model for the
PNAG synthase system in S. epidermidis and S. aureus. The analyses
presented here show that well-characterised Gram-negative bacte-
ria such as E. coli can synthesise and export PNAG exopolysaccha-
ride across their inner membrane without an IcaC homologue and
that the minimal components required for an ica operon in Gram-
positives are IcaAD and IcaB. As a result we conclude that IcaC can-
not be a core functional component of PNAG biosynthesis systems
and hence is unlikely to be the route of PNAG export (translocation
is likely performed by IcaAD alone). Furthermore, we propose that,
as IcaC is a member of the Acyl_transf_3 family (PF01757) and the
PNAG in the staphylococci has a known modiﬁcation with an
unknown mechanism of addition, it is possible that IcaC functions
as an O-succinyltransferase to modify the structure of the PNAG.
Enzymatic modiﬁcation of the key virulence factor PNAG is
likely to inﬂuence bioﬁlm accumulation and aid evasion of the host
immune system. If the positions of the O-succinyl modiﬁcations
were randomly distributed on the carbohydrate chain then it
would make it harder for the host to produce antibodies capable
of recognising the bacterium [29]. A number of studies have iden-
tiﬁed a role for IcaC in formation of a mature bioﬁlm, which in light
of our new analysis would suggest that O-succinylation is impor-
tant in vivo [11,12] and thus might represent a new therapeutic
target.
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